All L1 Capital convertibles have now been converted.
As of 2019-09-04, L1 Capital has converted all convertibles in the financing agreement initiated by the parties in 2017.
In order to counteract the dilution effect of the financing solution, Brighter has on several occasions during the agreement period distributed free shareholder warrants. These can be subscribed during the periods below.
The warrants are listed and traded under the short names BRIG TO3 and BRIG TO4.
One (1) TO3 can be exchanged for one (1) share, at a price of SEK 4.
October 11-25, 2019
April 10-24, 2020
One (1) TO4 can be exchanged for one (1) share, at a price of SEK 6.01.
February 22 - March 8, 2020
August 25 - September 8, 2020
For further information, please contact:
Ann Zetterberg, CFO
Phone: +46 708 37 21 23
About Brighter AB (publ).
Brighter is a Swedish-based company that, from a unique IP portfolio, creates smart solutions for one of healthcare’s biggest challenges: changing patient behavior. Chronic diseases such as diabetes are rapidly increasing, and account for an increasing share of healthcare costs globally. Brighter's Business Model and Multi-Sided Market Platform - The Benefit Loop®- is based on the fact that many special interests create value for each other. By increasing access to valid health data, Brighter creates value for all stakeholders in the care chain: patients and their close associates, healthcare providers, research institutes, the pharmaceutical industry, and society as a whole. Brighter is certified under ISO 13485. In 2019 the company won the Swecare Rising Stars Award. https://brighter.se/
The Company's shares are listed on Nasdaq First North Growth Market/BRIG. Brighter’s Certified Adviser is Eminova Fondkommission AB, +46 (0)8 – 684 211 00, email@example.com, www.eminova.se.